At CTE, we identify the overlap between the need for disease education and the strategic objectives of a pharmaceutical, biotech, or medical device brand to design resources within this common area. The treatment decision-making power is transferred into the hands of the patient and his/her caregiver. CTE’s educational initiatives provide patients with information on therapeutic topics related to their condition, not on specific products. The integrity of this information allows the patient the autonomy to make informed treatment decisions, while the content of this educational material is designed to enhance the brand message of the sponsoring company by driving home key messages of the brand.

All educational initiatives are customized in order to best align with the strategic goals of the sponsoring company’s brand team. These resources can become an extended offering for brand teams with limited use of the sponsoring companies’ manpower.

The measurement of an initiative’s success includes changes in attitudes and behaviors of patients and caregivers pertinent to the sponsor’s brand as well as the strong relationships formed with advocacy groups. These programs also offer an excellent opportunity to opt-in patients and caregivers to a database to receive additional information (in our experience, about 20% of attendees will do so). Companies that sponsor these educational programs find these opt-in databases to be a valuable resource to reinforce their brand’s key messages while providing quality content that works to maintain long-lasting relationships with their consumers.